Dielectric Constant and Conductivity of Blood Plasma: Possible Novel Biomarkers for Alzheimer's Disease

scientific article published on 13 February 2020

Dielectric Constant and Conductivity of Blood Plasma: Possible Novel Biomarkers for Alzheimer's Disease is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1155/2020/5756382
P932PMC publication ID7042553
P698PubMed publication ID32148652

P50authorErnest DalléQ90149231
P2093author name stringMusa V Mabandla
William M U Daniels
P2860cites workNeurobiological links between depression and AD: The role of TGF-β1 signaling as a new pharmacological target.Q50039451
High performance plasma amyloid-β biomarkers for Alzheimer's diseaseQ50107488
A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication.Q51760901
A practical analysis of the electrical conductivity of blood.Q52707582
Dielectric properties of human blood and erythrocytes at radio frequencies (0.2?10 MHz); dependence on cell volume fraction and medium compositionQ56975016
Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's diseaseQ64360652
Dielectric properties of human blood at microwave frequenciesQ72924398
Somatic variants in autosomal dominant genes are a rare cause of sporadic Alzheimer's diseaseQ90980821
Predicting diagnosis and cognition with 18F-AV-1451 tau PET and structural MRI in Alzheimer's diseaseQ91030167
Familial Alzheimer's disease-linked presenilin mutants and intracellular Ca2+ handling: A single-organelle, FRET-based analysisQ92045752
Familial Alzheimer's disease patient-derived neurons reveal distinct mutation-specific effects on amyloid betaQ93066085
Refining memory assessment of elderly people with cognitive impairment: Insights from the short-term memory binding testQ93179618
Mechanism of amyloid plaque formation suggests an intracellular basis of Abeta pathogenicityQ30493579
Truncated beta-amyloid peptide species in pre-clinical Alzheimer's disease as new targets for the vaccination approachQ31144656
Biomarkers in translational research of Alzheimer's diseaseQ33556189
Blood-based biomarkers of microvascular pathology in Alzheimer's diseaseQ33625663
Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plansQ33846034
3D maps localize caudate nucleus atrophy in 400 Alzheimer's disease, mild cognitive impairment, and healthy elderly subjectsQ33990243
Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategiesQ34160761
The passive electrical properties of biological systems: their significance in physiology, biophysics and biotechnologyQ34173531
Identifying and validating biomarkers for Alzheimer's diseaseQ34468961
Amyloid-β immunization enhances neurogenesis and cognitive ability in neonatal mice.Q35792042
Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic CounselorsQ35889850
The Alzheimer's disease beta-secretase enzyme, BACE1.Q36397690
Role of biomarkers in studies of presymptomatic Alzheimer's diseaseQ37549214
Biomarkers for Alzheimer's disease and other forms of dementia: clinical needs, limitations and future aspectsQ37606705
Alzheimer's disease is incurable but preventableQ37698040
Biomarkers for Alzheimer's disease therapeutic trialsQ37815749
Developing predictive CSF biomarkers-a challenge critical to success in Alzheimer's disease and neuropsychiatric translational medicineQ37835982
Alzheimer's disease: cholesterol a menace?Q37899391
Blood and plasma-based proteomic biomarker research in Alzheimer's diseaseQ38022421
Beta-amyloid monomer and insulin/IGF-1 signaling in Alzheimer's diseaseQ38034089
A review on Alzheimer's disease pathophysiology and its management: an updateQ38364941
The dielectric properties of biological tissues: I. Literature surveyQ41235855
Dielectric properties of blood: an investigation of haematocrit dependenceQ42594980
Mémantine (Ebixa): a new therapeutic strategy for the treatment of moderate to severe forms of Alzheimer's diseaseQ44804254
Dielectric properties of human colostrum at microwave frequencies.Q46831580
A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's diseaseQ47583762
Poly-N-methylated Aβ-Peptide C-Terminal fragments (MEPTIDES) reverse the deleterious effects of amyloid-β in ratsQ47673729
Capsaicin Attenuates Amyloid-β-Induced Synapse Loss and Cognitive Impairments in MiceQ47985863
Antibodies against beta-amyloid slow cognitive decline in Alzheimer's diseaseQ48300537
Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinicsQ48346421
A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative StudyQ48725577
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P921main subjectblood plasmaQ79749
biomarkerQ864574
P304page(s)5756382
P577publication date2020-02-13
P1433published inOxidative medicine and cellular longevityQ26840015
P1476titleDielectric Constant and Conductivity of Blood Plasma: Possible Novel Biomarkers for Alzheimer's Disease
P478volume2020

Search more.